Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 2,057,440 | 1,999,021 | 1,797,582 | 1,669,968 | 1,513,008 |
Marketable Securities | 290,752 | 285,054 | 283,385 | 292,425 | 288,369 |
Receivables | 616,300 | 516,689 | 438,170 | 397,357 | 481,994 |
Inventories | 27,904 | 21,303 | 16,675 | 16,700 | 16,425 |
TOTAL | $3,118,674 | $2,923,797 | $2,620,060 | $2,449,969 | $2,359,894 |
Non-Current Assets | |||||
PPE Net | 723,920 | 686,718 | 661,360 | 594,670 | 559,625 |
Investments And Advances | 221,266 | 192,096 | 222,370 | 202,174 | 222,301 |
Intangibles | 150,755 | 156,139 | 317,116 | 166,907 | 172,291 |
Other Non-Current Assets | 718,737 | 240,081 | 83,717 | 247,716 | 246,807 |
TOTAL | $1,814,678 | $1,275,034 | $1,284,563 | $1,211,467 | $1,201,024 |
Total Assets | $4,933,352 | $4,198,831 | $3,904,623 | $3,661,436 | $3,560,918 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 172,110 | 114,509 | 122,100 | 85,058 | 98,767 |
Accrued Expenses | 679,563 | 625,803 | 535,816 | 536,506 | 530,144 |
TOTAL | $854,308 | $742,712 | $660,324 | $623,881 | $631,195 |
Non-Current Liabilities | |||||
Other Non-Current Liabilities | 277,408 | 276,086 | 276,600 | 277,557 | 285,882 |
TOTAL | $309,040 | $307,462 | $308,438 | $309,711 | $318,455 |
Total Liabilities | $1,163,348 | $1,050,174 | $968,762 | $933,592 | $949,650 |
Shareholders' Equity | |||||
Shares Outstanding, K | 221,325 | 220,891 | 220,835 | 219,924 | 219,844 |
Common Shares | 221 | 221 | 220 | 220 | 219 |
Retained earnings | -777,874 | -1,341,725 | -1,523,464 | -1,672,920 | -1,726,455 |
Other shareholders' equity | -19,454 | -18,646 | -18,273 | -20,358 | -15,360 |
TOTAL | $3,770,004 | $3,148,657 | $2,935,861 | $2,727,844 | $2,611,268 |
Total Liabilities And Equity | $4,933,352 | $4,198,831 | $3,904,623 | $3,661,436 | $3,560,918 |